Encore Global Management, LP

Position in RPRX — Royalty Pharma plc

CIK 2135356 HOUSTON, TX

Position in RPRX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$112,140

New position

Shares Held

2,000

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#517

of 641 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Encore Global Management, LP holds $6,082,178 across 5 Biotechnology names. RPRX ranks #4 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	5,050	$3,148,877
2	CRSP	CRISPR Therapeutics AG	30,557	$1,666,578
3	CYTK	Cytokinetics Inc	12,731	$1,084,553
4	RPRX	Royalty Pharma plc This page	2,000	$112,140
5	MRNA	Moderna, Inc.	1,000	$70,030

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$112,140	2,000	—	Shares	Sole	2026-08-11
No filing history on record for this holder in this stock.